dosing

*Inhaled corticosteroids.
Administered in the morning and evening.

Tolerability
In clinical studies, adverse events (regardless of causality) occurring at an incidence of ≥3% and more commonly than with placebo*†

side effects

*All treatments were administered as 2 inhalations twice daily.
The incidence of common adverse events in the table above is based upon three 12-week, double-blind, placebo-controlled US clinical trials in which 401 adult and adolescent patients aged 12 years and older were treated twice daily with 2 inhalations of SYMBICORT 80/4.5 mcg or SYMBICORT 160/4.5 mcg, budesonide HFA metered-dose inhaler (MDI) 80 or 160 mcg, formoterol dry powder inhaler (DPI) 4.5 mcg, or placebos (MDI and DPI).

SYMBICORT helps give patients a reassuring sense of control

Help For Your Patients

Is SYMBICORT on
formulary?

Nationwide, over 80% of patients with prescription drug coverage pay a Tier 1 or Tier 2 copay.1

Use the free formulary status tool to quickly determine the formulary status of asthma controllers, including SYMBICORT, in your area.


Patient tools and
resources

Video demonstrations and a patient support program may help you keep asthma patients on their maintenance therapy.

Learn More
Have a patient who can't afford medication?

Visit the AstraZeneca US corporate Web site to see if he or she qualifies for the AstraZeneca Patient Prescription Assistance Program.

HowCan We Help You Today?

Dosing

enlarge

Questions about dosing?

Learn more about the recommended dosing of SYMBICORT.

Dosing
Side Effects

enlarge

Questions about common side effects?

Learn more about the safety profile of SYMBICORT.

Safety Profile

Looking for SYMBICORT updates?

Register

Sign up to receive a notice when new product
information or patient education materials are
added to this site.

 

Individual costs may vary by plan.